col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


47 Results       Page 1

 [1] 
Springer-Verlag: 3 Biotech
  original article Date Title Authors   All Authors
1 [GO] 2025―May―15 Innovation landscape in nanobiosensors for COVID-19 detection and future implications for a resilient Global Health Security Abhijit Poddar, S. R. Rao
2 [GO] 2025―Apr―05 Rerouting therapeutic peptides and unlocking their potential against SARS-CoV2 Namrata Prashar, Saharuddin Bin Mohammed, N. S. Raja, Habeeb Shaik Mohideen
3 [GO] 2024―Aug―25 Structural insights into Furin enzyme inhibition to block SARS-CoV-2 spike protein cleavage: an in-silico approach Ramakrishnan Jaganathan, Poomani Kumaradhas
4 [GO] 2024―Aug―06 In silico screening and evaluation of antiviral peptides as inhibitors against ORF9b protein of SARS-CoV-2 Gaurav Sharma, Prateek Paul, Ananya Dviwedi, Parneet Kaur, Pradeep Kumar, V. Kumar Gupta, et al. (+2)
5 [GO] 2024―Apr―09 Wastewater treatment from a science faculty during the COVID-19 pandemic by using ammonium-oxidising and heterotrophic bacteria Lucas D. Pedroza-Camacho, Paula A. Ospina-Sánchez, Felipe A. Romero-Perdomo, Nury G. Infante-González, Diana M. Paredes-Céspedes, Balkys Quevedo-Hidalgo, et al. (+3)
6 [GO] 2023―Aug―31 In silico guided screening of active components of C. lanceolata as 3-chymotrypsin-like protease inhibitors of novel coronavirus Ganesh Sharma, Neeraj Kumar, Chandra Shekhar Sharma, Shashank Shekher Mishra
7 [GO] 2023―Aug―30 Understanding the role of conserved proline and serine residues in the SARS-CoV-2 spike cleavage sites in the virus entry, fusion, and infectivity Ritika Khatri, Bharat Lohiya, Gurleen Kaur, Vikas Maithil, Abhishek Goswami, Debapriyo Sarmadhikari, et al. (+2)
8 [GO] 2023―Aug―14 De novo design of bioactive phenol and chromone derivatives for inhibitors of Spike glycoprotein of SARS-CoV-2 in silico Joan Petrus Oliveira Lima, Aluísio Marques da Fonseca, Gabrielle Silva Marinho, Matheus Nunes da Rocha, Emanuelle Machado Marinho, Helcio Silva dos Santos, et al. (+4)
9 [GO] 2023―Jul―25 A novel monospecific tetravalent IgG1-(scFv)2 version shown enhanced neutralizing and Fc-mediated effector functions against SARS-CoV-2 Zhang-zhao Gao, Jing-yu Jiao, Ya-qiong Zhou, Jian Qi, Shan-shan Zhu, Jing-ya Xu, et al. (+2)
10 [GO] 2023―Jun―11 An overview of opportunistic fungal infections associated with COVID-19 Navidita Kangabam, V. Nethravathy
11 [GO] 2023―May―13 In-silico study: docking simulation and molecular dynamics of peptidomimetic fullerene-based derivatives against SARS-CoV-2 Mpro Noha A. Saleh
12 [GO] 2023―Mar―26 Deciphering molecular mechanisms of SARS-CoV-2 pathogenesis and drug repurposing through GRN motifs: a comprehensive systems biology study Marzieh Sameni, Seyed Amir Mirmotalebisohi, Zeinab Dehghan, Raziyeh Abooshahab, Yalda Khazaei-Poul, Maryam Mozafar, Hakimeh Zali
13 [GO] 2023―Jan―05 Comparative docking studies of drugs and phytocompounds for emerging variants of SARS-CoV-2 Ananya Chugh, Ishita Sehgal, Nimisha Khurana, Kangna Verma, Rajan Rolta, Pranjal Vats, et al. (+6)
14 [GO] 2022―Dec―16 A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2 Udit Chaube, Bhumika D. Patel, Hardik G. Bhatt
15 [GO] 2022―Dec―11 Susceptibility of SARS Coronavirus-2 infection in domestic and wild animals: a systematic review Sudhanarayani S. Rao, Krupakar Parthasarathy, Vignesh Sounderrajan, K. Neelagandan, Pradeep Anbazhagan, Vaishnavi Chandramouli
16 [GO] 2022―Nov―07 Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics José Ednésio da Cruz Freire, José Edvar Monteiro Júnior, Daniel Pascoalino Pinheiro, Grayce Ellen da Cruz Paiva Lima, Camila Lopes do Amaral, Victor Rezende Veras, et al. (+8)
17 [GO] 2022―Oct―15 Development of CD163 receptor-based enzyme-linked immunosorbent assay for diagnosis of porcine reproductive and respiratory syndrome virus Rajib Deb, Ajay Kumar Yadav, Gyanendra Singh Sengar, Joyshikh Sonowal, D. Lalita, Seema Rani Pegu, et al. (+8)
18 [GO] 2022―Oct―13 A comprehensive mini-review on amyloidogenesis of different SARS-CoV-2 proteins and its effect on amyloid formation in various host proteins Prakriti Seth, Nandini Sarkar
19 [GO] 2022―Sep―21 Pharmacogenomics deliberations of 2-deoxy-d-glucose in the treatment of COVID-19 disease: an in silico approach Navya B. Prabhu, Chigateri M. Vinay, Kapaettu Satyamoorthy, Padmalatha S. Rai
20 [GO] 2022―Aug―23 Computational design of a broad-spectrum multi-epitope vaccine candidate against seven strains of human coronaviruses Avinash Kumar, Ekta Rathi, Suvarna Ganesh Kini
21 [GO] 2022―Aug―17 Monoclonal antibodies: a remedial approach to prevent SARS-CoV-2 infection Sonu Kumar, Debrupa Dutta, Velayutham Ravichandiran, Soumi Sukla
22 [GO] 2022―Aug―02 Characterization of a broadly cross reactive tetravalent human monoclonal antibody, recognizing conformational epitopes in receptor binding domain of SARS-CoV-2 Sonal Garg, Nisha Raj, Asha Lukose, Deepti Jamwal, Hilal Ahmed Parray, Sandeep Kumar, et al. (+9)
23 [GO] 2022―Mar―03 Insights into the structure and dynamics of SARS-CoV-2 spike glycoprotein double mutant L452R-E484Q Shahzaib Ahamad, Kanipakam Hema, Shahnawaz Ahmad, Vijay Kumar, Dinesh Gupta
24 [GO] 2021―Dec―12 COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review Faizan Zarreen Simnani, Dibyangshee Singh, Ramneet Kaur
25 [GO] 2021―Dec―06 COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis Rachel Samson, Mahesh Dharne
26 [GO] 2021―Jun―28 Use of nanotechnology in combating coronavirus Saee Gharpure, Balaprasad Ankamwar
27 [GO] 2021―Apr―25 Mutational heterogeneity in spike glycoproteins of severe acute respiratory syndrome coronavirus 2 Aanchal Mathur, Sibi Raj, Niraj Kumar Jha, Saurabh Kumar Jha, Brijesh Rathi, Dhruv Kumar
28 [GO] 2021―Mar―27 A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing S. Udhaya Kumar, N. Madhana Priya, S. R. Nithya, Priyanka Kannan, Nikita Jain, D. Thirumal Kumar, et al. (+4)
29 [GO] 2021―Feb―22 Cordifolioside: potent inhibitor against Mpro of SARS-CoV-2 and immunomodulatory through human TGF-β and TNF-α Munikumar Manne, Giridhar Goudar, Seshadri Reddy Varikasuvu, Mahadev C. Khetagoudar, Hema Kanipakam, Pradeep Natarajan, et al. (+7)
30 [GO] 2021―Feb―09 Screening of JAK-STAT modulators from the antiviral plants of Indian traditional system of medicine with the potential to inhibit 2019 novel coronavirus using network pharmacology Pukar Khanal, Taaza Duyu, B. M. Patil, Yadu Nandan Dey, Ismail Pasha, Rohini S. Kavalapure, et al. (+2)
31 [GO] 2021―Feb―01 Structural analysis of COVID-19 spike protein in recognizing the ACE2 receptor of different mammalian species and its susceptibility to viral infection Tirthankar Koley, Shivani Madaan, Sanghati Roy Chowdhury, Manoj Kumar, Punit Kaur, Tej Pal Singh, Abdul S. Ethayathulla
32 [GO] 2021―Jan―25 Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective Yashwant Kumar Ratre, Namrata Kahar, L. V. K. S. Bhaskar, Antaripa Bhattacharya, Henu Kumar Verma
33 [GO] 2021―Jan―24 Screening of potent drug inhibitors against SARS-CoV-2 RNA polymerase: an in silico approach Sanjay Kumar Singh, Atul Kumar Upadhyay, M. Sudhakara Reddy
34 [GO] 2021―Jan―22 Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19) Salma Bessalah, Samira Jebahi, Naceur Mejri, Imed Salhi, Touhami Khorchani, Mohamed Hammadi
35 [GO] 2021―Jan―13 Factual insights of the allosteric inhibition mechanism of SARS-CoV-2 main protease by quercetin: an in silico analysis Shalja Verma, Anand Kumar Pandey
36 [GO] 2021―Jan―12 Smart technologies driven approaches to tackle COVID-19 pandemic: a review Hameed Khan, K. K. Kushwah, Saurabh Singh, Harshika Urkude, Muni Raj Maurya, Kishor Kumar Sadasivuni
37 [GO] 2021―Jan―12 In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in Ayurveda medicine in inhibiting SARS-CoV-2 Shridhar Hiremath, H. D. Vinay Kumar, M. Nandan, M. Mantesh, K. S. Shankarappa, V. Venkataravanappa, et al. (+2)
38 [GO] 2021―Jan―12 Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches Ratnadeep Saha, Pratik Ghosh, V. L. S. Prasad Burra
39 [GO] 2021―Jan―09 Recent biotechnological advances as potential intervention strategies against COVID-19 Naun Lobo-Galo, Juan-Carlos Gálvez-Ruíz, Ana P. Balderrama-Carmona, Norma P. Silva-Beltrán, Eduardo Ruiz-Bustos
40 [GO] 2020―Nov―26 Probiotics in the prophylaxis of COVID-19: something is better than nothing Kushal Gohil, Rachel Samson, Syed Dastager, Mahesh Dharne
41 [GO] 2020―Nov―11 Immunotherapeutics for Covid-19 and post vaccination surveillance N. S. Sampath Kumar, Anjani Devi Chintagunta, S. P. Jeevan Kumar, Sharmili Roy, Mahesh Kumar
42 [GO] 2020―Oct―21 In silico analysis of ACE2 orthologues to predict animal host range with high susceptibility to SARS-CoV-2 El Mehdi Bouricha, Mohammed Hakmi, Jihane Akachar, Lahcen Belyamani, Azeddine Ibrahimi
43 [GO] 2020―Oct―19 Targeting complement cascade: an alternative strategy for COVID-19 Sureshbabu Ram Kumar Pandian, Sankarganesh Arunachalam, Venkataraman Deepak, Selvaraj Kunjiappan, Krishnan Sundar
44 [GO] 2020―Sep―16 An overview of COVID-19 with an emphasis on computational approach for its preventive intervention Divya Mishra, Ashish Mishra, Vivek K. Chaturvedi, M. P. Singh
45 [GO] 2020―Sep―10 Identification of potential mRNA panels for severe acute respiratory syndrome coronavirus 2 (COVID-19) diagnosis and treatment using microarray dataset and bioinformatics methods Basavaraj Vastrad, Chanabasayya Vastrad, Anandkumar Tengli
46 [GO] 2020―Aug―17 Investigation on the impacts of COVID-19 quarantine on society and environment: Preventive measures and supportive technologies Santhosh Kumar Kumaravel, Ranjith Kumar Subramani, Tharun Kumar Jayaraj Sivakumar, Rajvikram Madurai Elavarasan, Ajayragavan Manavalanagar Vetrichelvan, Annapurna Annam, Umashankar Subramaniam
47 [GO] 2020―Aug―11 Biosensors: frontiers in rapid detection of COVID-19 Rachel Samson, Govinda R. Navale, Mahesh S. Dharne
 [1] 

47 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec